GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Here’s a negative review of rFVIIa in acquired
hemophilia, where NovoSeven is already approved
by the FDA. Does anyone have access to this paper?

http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17975872&ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum

>>
Review: rFVIIa Does Not Differ from Placebo
for Prevention Or Treatment of Bleeding in
Patients Without Hemophilia

ACP J Club. 2007 November/December;147(3):70.

Cosmi B.

S. Orsola-Malpighi University Hospital, Bologna, Italy.
<<